Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNC | P24863 | 1/20 | 0.46 |
| ▸ | CDK8 | P49336 | 1/20 | 0.46 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.41 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.41 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.41 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | GFER | P55789 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | PTGES | O14684 | 2/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.39 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.39 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.39 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.39 |
| ▸ | TBXAS1 | P24557 | 5/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16605161 | 0.89 | SLC2A1 (0.49) | CCNCCDK8PTGER1PTGER4PTGER3 | |
| SCHEMBL1808439 | 0.88 | CCNC (0.46) | CCNCCDK8PTGER1PTGER4PTGER3 | |
| SCHEMBL16605163 | 0.87 | FFAR1 (0.50) | PTGER1PTGER4PTGER3PTGER2FFAR1 | |
| SCHEMBL1805030 | 0.86 | CYP11B2 (0.47) | CCNCCDK8KDM4EALDH1A1FFAR1 | |
| SCHEMBL1811354 | 0.80 | FFAR1 (0.50) | PTGER1PTGER4PTGER3PTGER2KDM4E | |
| SCHEMBL38659420 | 0.80 | FFAR1 (0.50) | PTGER1PTGER4PTGER3PTGER2KDM4E | |
| SCHEMBL1817206 | 0.78 | CCNC (0.39) | CCNCCDK8TBXAS1SLC2A1 | |
| SCHEMBL1804118 | 0.77 | CCNC (0.47) | CCNCCDK8PTGER1PTGER4PTGER3 | |
| SCHEMBL1887137 | 0.77 | FFAR1 (0.53) | PTGER1PTGER4PTGER3PTGER2FFAR1 | |
| SCHEMBL1815801 | 0.77 | CYP11B2 (0.43) | CCNCCDK8KDM4EALDH1A1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170204197-A1 | Goodpasture Antigen Binding Protein Detection and Inhibition and its Use in Diabetes | FIBROSTATIN S L (ES) | 2017-07-20 | — | — | US | disclosed |
| US-20150320730-A1 | GPBP-1 inhibition and its therapeutic use | FIBROSTATIN, S.L. (ES) | 2015-11-12 | — | — | US | disclosed |
| US-9066938-B2 | GPBP-1 inhibition and its therapeutic use | Fibrostein, S.L. (ES) | 2015-06-30 | — | — | US | disclosed |
| US-20150093378-A1 | Goodpasture Antigen Binding Protein Detection and Inhibition and its Use in Diabetes | FIBROSTATIN, S.L. (ES) | 2015-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170204197-A1 | Goodpasture Antigen Binding Protein Detection and Inhibition and its Use in Diabetes | CD2BP2, SAP30BP, LY96 | CCNC 3192/4885CDK8 2689/4885PTGER1 2343/4885 |
| US-20150093378-A1 | Goodpasture Antigen Binding Protein Detection and Inhibition and its Use in Diabetes | CD2BP2, SAP30BP, LY96 | CCNC 3192/4885CDK8 2689/4885PTGER1 2343/4885 |
| US-20150320730-A1 | GPBP-1 inhibition and its therapeutic use | ABCC1, ABCC8, ABCB1 | CCNC 715/4885CDK8 861/4885PTGER1 888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.